STOCK MARKET BSE NSE

Enough HCQ stock, says Centre, but no details shared

The Union government has drawn flak in last few days after it removed the export ban on the drug—reportedly under the US pressure—within two days of imposing the ban.

Published: 09th April 2020 08:57 AM  |   Last Updated: 09th April 2020 08:57 AM   |  A+A-

Medics wearing protective suits attend to patients at a Delhi Government-run clinic during the nationwide lockdown in New Delhi on Wednesday | Pti

By Express News Service

NEW DELHI:  The Centre on Wednesday has said that India has “sufficient” stock of anti-malaria drug Hydroxychloroquine, being used for COVID 19 patients in the country, but refused to share details of the stock. The drug along with antibiotic Azithromycin has been recommended for severely ill COVID-19 patients in India and healthcare workers and close contacts of those who are infected have also been advised to use the drug to prevent infection.

The Union government has drawn flak in last few days after it removed the export ban on the drug—reportedly under the US pressure—within two days of imposing the ban. “It is ensured that not only today even in future there will not be any lack of HCQ as and when needed,’’ Lav Agarwal, Joint Secretary in the Union Ministry of Health and Family Welfare said on Wednesday, announcing that the country has reported 773 cases and 32 deaths in 24 hours.

The cumulative count of the novel coronavirus cases in India now stands at 5,194 and 402 patients have also been declared as “cured” after treatment. The government on Wednesday complimented measures taken by some districts that have emerged as best practices. It includes Pune district which sealed the central region of Pune and Kondhwa area effectively and carried out a door-to-door survey of homes located across 35 sq km area. The teams there have also been checking on persons with co-morbidity such as diabetes and hypertension apart from travel history and contact tracing.

Another district that was mentioned in the daily briefing was Pathanamthitta in Kerala that ensured surveillance, gathering travel history, contact tracing, quarantine facilities and providing essential and psychological support to the needy. Agarwal maintained that as the number of COVID-19 cases is rising in the country, India’s response and preparedness is also intensifying accordingly. Adding that in hospitals, the main focus is on infection prevention and control measures so that health workers aren’t infected. 
The Centre also launched a training module for management of COVID-19 named “integrated govt Online training” portal on DIKSHA platform for the capacity building of frontline workers to handle the pandemic efficiently. 

Stay up to date on all the latest Nation news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp